
Lowey Dannenberg joined earlier investor alerts after a July 29, 2026 FTC lawsuit, backed by Utah and California, accused Hims & Hers of unauthorized subscriptions and sharing sensitive health data with Meta and Snap.
Lowey Dannenberg has joined other investor law firms investigating possible federal securities laws violations at Hims & Hers Health, Inc. after a July 29, 2026 complaint by the Federal Trade Commission, joined by Utah and California, accused the company of deceptive subscription and privacy practices. The complaint alleges Hims & Hers charged consumers for prescriptions before a provider determined treatment was appropriate, enrolled users in recurring subscriptions without consent, made cancellations difficult, and shared sensitive health information with Meta and Snap despite privacy assurances. Earlier investor alerts tied the case to a 14.73% one-day stock decline to $25.00, while Lowey Dannenberg said the shares fell $3.05, or about 10.40%, during intraday trading the same day.